Search Results for "sofosbuvir"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for sofosbuvir. Results 1 to 4 of 4 total matches.
See also: Harvoni, Sovaldi

Drugs for Hepatitis C Virus Infection

   
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024  (Issue 1714)
/pibrentasvir (Mavyret) or 12 weeks of sofosbuvir/velpatasvir (Epclusa, and generic); these combinations ...
About 2.5 million persons in the US had hepatitis C between 2017 and 2020. Guidelines from the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) on management of hepatitis C virus (HCV) infection were updated in 2023.
Med Lett Drugs Ther. 2024 Oct 28;66(1714):169-74   doi:10.58347/tml.2024.1714a |  Show IntroductionHide Introduction

Figure 1: Treatment of Hepatitis C Virus Infection in Treatment-Naive Adults (online only)

   
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024  (Issue 1714)
.                                                                                                                                                                                                                                                                                                                                                                   Brand Name Key Glecaprevir/pibrentasvir = Mavyret Sofosbuvir/velpatasvir = Epclusa* Ledipasvir ...
View Figure 1: Treatment of Hepatitis C Virus Infection in Treatment-Naive Adults
Med Lett Drugs Ther. 2024 Oct 28;66(1714):e174   doi:10.58347/tml.2024.1714e |  Show IntroductionHide Introduction

Table 3: Some Drug Interactions with DAAs for HCV Infection (online only)

   
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024  (Issue 1714)
Sofosbuvir/velpatasvir (Epclusa, and authorized generic) P-gp inducers2 Decreased DAA serum concentrations ...
View Table 3: Some Drug Interactions with DAAs for HCV Infection
Med Lett Drugs Ther. 2024 Oct 28;66(1714):e175   doi:10.58347/tml.2024.1714f |  Show IntroductionHide Introduction

Table: Inhibitors and Inducers of CYP Enzymes, P-Glycoprotein, and Other Transporters (online only)

   
The Medical Letter on Drugs and Therapeutics • Feb 06, 2023  (Issue 1669)
sofosbuvir/velpatasvir sotorasib telaprevir telithromycin tolvaptan velpatasvir vemurafenib verapamil ...
View the Inhibitors and Inducers of CYP Enzymes, P-Glycoprotein, and Other Transporters tables
Med Lett Drugs Ther. 2023 Feb 6;65(1669):e28-30   doi:10.58347/tml.2023.1669g |  Show IntroductionHide Introduction